Hepatitis C is a blood-borne viral disease that swells the liver that is frequently transmitted through unprotected sex or unsafe injections. Hepatitis C virus (HCV) acute infections are generally asymptomatic, but when left untreated it become a chronic problem and can lead to the development of cirrhosis or liver cancer. While certain HCV infections are asymptomatic, others will produce fever, fatigue, decreased appetite, nausea, vomiting, abdominal pain, dark urine, grey feces, joint pain, and jaundice.
When cannabis activates the CB2 receptor, it produces anti-inflammatory effects which can be beneficial for alcoholic fatty liver, hepatic inflammation, liver injury, regeneration, and fibrosis, all of which are helpful for those diagnosed with HCV. One study found cannabinoids reduced inflammation in damaged livers, suggesting its potential as a treatment option for hepatitis. Earlier studies had suggested cannabis might worsen cirrhosis, fibrosis, and other liver diseases, but more recent studies have disputed this, claiming there is no such link. In fact, now researchers claim the potential benefits of cannabis as an HCV treatment option outweigh the risks. The antiviral medications used to treat HCV can produce unwanted side effects, but cannabis has been reported to help manage nausea and other side effects, helping patients stick with their treatment.
This information has been brought to you by Medical Marijuana Inc. and approved by our Chief Medical Officer.